the market?
Novartis
NYSE: NVS
74.62
-0.01
(-0.01%)
| Today's Open | $74.87 |
|---|---|
| Previous Close | $74.63 |
| Daily Range | $74.45 - $75.73 |
| 52-Week Range | $51.20 - $75.73 |
| Market Cap | $183.4B |
| P/E Ratio | 19.19 |
| Dividend (Yield) | $2.53 (2.8%) |
| Ex-Dividend Date Dividend Pay Date |
02/26/13 04/05/13 |
| Volume | 1,226,169 |
| Average Daily Volume | 1,456,238 |
| Current FY EPS | $5.11 |
How do you think NVS
will perform against the market?
Top NVS Bull/Bear Pitches
MarginofSafetyIn (< 20)
Submitted
November 21, 2010
Novartis Review: Could be a good pharma pick Intro Novartis is a “large Pharma” company with 5 major operating units: Branded pharmaceuticals, Generic pharmaceuticals, diagnostics, vaccines and follo … More
News & Commentary
Another Multiple Sclerosis Winner for Biogen
Biogen submits Plegridy for FDA approval.Johnson & Johnson Stock Checkup for May
With shares on a steady rise so far in 2013, how does Johnson & Johnson stock look now? Find out in this month's stock checkup.Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.The 5 Richest Countries in the World
These five countries from four different regions have populations that enjoy the benefits of a strong economy.Sector
Healthcare
Industry
Drugs
Novartis (NVS) Description
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/
CEO Rating by Glassdoor
More details for Novartis Jobs
Novartis reviews from employees
